Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-12-14

Clinical Trial Update: Refractive Treatment of Early Keratoconus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating refractive treatment for early keratoconus; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Keratoconus | Phase 3 | Status: UNKNOWN